Christopher A. Klebanoff: Featured News

MSK physician-scientist Christopher Klebanoff in lab looking at slide.
Article
Why Does CAR-T Cell Therapy Fail? MSK Research Points to FAS-L Proteins

Read about a new discovery that could lead to more powerful cell-based therapies for cancer.
A pipette inserted into a tube in a rack of test tubes
A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDS 

Laboratory research shows how it may be possible to develop an immunotherapy-based approach for treating aggressive forms of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
A cartoon of a person hiding behind a newspaper and sunglasses.
In the Lab
CAR T Cells Get an Invisibility Cloak

Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.